These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 29133279)

  • 1. Effect of 17β-estradiol on estrogen receptor negative breast cancer cells in an osteolytic mouse model.
    Cohen DJ; Patel V; Verma A; Boyan BD; Schwartz Z
    Steroids; 2019 Feb; 142():28-33. PubMed ID: 29133279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Estradiol induces bone osteolysis in triple-negative breast cancer via its membrane-associated receptor ERα36.
    Cohen DJ; Dennis CD; Deng J; Boyan BD; Schwartz Z
    JBMR Plus; 2024 May; 8(5):ziae041. PubMed ID: 38644978
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estradiol enhances osteolytic lesions in mice inoculated with human estrogen receptor-negative MDA-231 breast cancer cells in vivo.
    Winding B; Misander H; Høegh-Andersen P; Brünner N; Foged NT
    Breast Cancer Res Treat; 2003 Mar; 78(2):205-16. PubMed ID: 12725420
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal impact of 17β-estradiol in T cell-deficient mice: age-dependent bone effects and osteosarcoma formation.
    Cheng JN; Frye JB; Whitman SA; Funk JL
    Clin Exp Metastasis; 2020 Apr; 37(2):269-281. PubMed ID: 31863240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine kinase 1 activation by estrogen receptor α36 contributes to tamoxifen resistance in breast cancer.
    Maczis MA; Maceyka M; Waters MR; Newton J; Singh M; Rigsby MF; Turner TH; Alzubi MA; Harrell JC; Milstien S; Spiegel S
    J Lipid Res; 2018 Dec; 59(12):2297-2307. PubMed ID: 30315000
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interrogating Estrogen Signaling Pathways in Human ER-Positive Breast Cancer Cells Forming Bone Metastases in Mice.
    Cheng JN; Frye JB; Whitman SA; Ehsani S; Ali S; Funk JL
    Endocrinology; 2024 Apr; 165(6):. PubMed ID: 38715255
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression and localization of estrogen receptor in human breast cancer and its clinical significance.
    Li L; Wang Q; Lv X; Sha L; Qin H; Wang L; Li L
    Cell Biochem Biophys; 2015 Jan; 71(1):63-8. PubMed ID: 25113640
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hedgehog signaling molecule Gli2 induces parathyroid hormone-related peptide expression and osteolysis in metastatic human breast cancer cells.
    Sterling JA; Oyajobi BO; Grubbs B; Padalecki SS; Munoz SA; Gupta A; Story B; Zhao M; Mundy GR
    Cancer Res; 2006 Aug; 66(15):7548-53. PubMed ID: 16885353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vascular endothelial growth factor is a target gene for estrogen receptor and contributes to breast cancer progression.
    Applanat MP; Buteau-Lozano H; Herve MA; Corpet A
    Adv Exp Med Biol; 2008; 617():437-44. PubMed ID: 18497067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1alpha,25-Dihydroxyvitamin D3 down-regulates estrogen receptor abundance and suppresses estrogen actions in MCF-7 human breast cancer cells.
    Swami S; Krishnan AV; Feldman D
    Clin Cancer Res; 2000 Aug; 6(8):3371-9. PubMed ID: 10955825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Membrane estrogen signaling enhances tumorigenesis and metastatic potential of breast cancer cells via estrogen receptor-α36 (ERα36).
    Chaudhri RA; Olivares-Navarrete R; Cuenca N; Hadadi A; Boyan BD; Schwartz Z
    J Biol Chem; 2012 Mar; 287(10):7169-81. PubMed ID: 22247547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor-alpha 36 mediates the anti-apoptotic effect of estradiol in triple negative breast cancer cells via a membrane-associated mechanism.
    Chaudhri RA; Hadadi A; Lobachev KS; Schwartz Z; Boyan BD
    Biochim Biophys Acta; 2014 Nov; 1843(11):2796-806. PubMed ID: 25108195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ERα36-GPER1 Collaboration Inhibits TLR4/NFκB-Induced Pro-Inflammatory Activity in Breast Cancer Cells.
    Notas G; Panagiotopoulos A; Vamvoukaki R; Kalyvianaki K; Kiagiadaki F; Deli A; Kampa M; Castanas E
    Int J Mol Sci; 2021 Jul; 22(14):. PubMed ID: 34299224
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17β-Estradiol inhibits testosterone-induced cell proliferation in HepG2 by modulating the relative ratios of 3 estrogen receptor isoforms to the androgen receptor.
    Xu Z; Liu J; Jianxin C; Yongliang Z; Pan X
    J Cell Biochem; 2018 Nov; 119(10):8659-8671. PubMed ID: 30058741
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Role for TGFβ Signaling in Preclinical Osteolytic Estrogen Receptor-Positive Breast Cancer Bone Metastases Progression.
    Cheng JN; Frye JB; Whitman SA; Kunihiro AG; Pandey R; Funk JL
    Int J Mol Sci; 2021 Apr; 22(9):. PubMed ID: 33923316
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NDV-D90 inhibits 17β-estradiol-mediated resistance to apoptosis by differentially modulating classic and nonclassic estrogen receptors in breast cancer cells.
    Shan P; Tang B; Xie S; Zhang Z; Fan J; Wei Z; Song C
    J Cell Biochem; 2021 Jan; 122(1):3-15. PubMed ID: 32985706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Up-regulation of PI3K/Akt signaling by 17beta-estradiol through activation of estrogen receptor-alpha, but not estrogen receptor-beta, and stimulates cell growth in breast cancer cells.
    Lee YR; Park J; Yu HN; Kim JS; Youn HJ; Jung SH
    Biochem Biophys Res Commun; 2005 Nov; 336(4):1221-6. PubMed ID: 16169518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model.
    Mbalaviele G; Dunstan CR; Sasaki A; Williams PJ; Mundy GR; Yoneda T
    Cancer Res; 1996 Sep; 56(17):4063-70. PubMed ID: 8752180
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor action of physiological estradiol on tamoxifen-stimulated breast tumors grown in athymic mice.
    Yao K; Lee ES; Bentrem DJ; England G; Schafer JI; O'Regan RM; Jordan VC
    Clin Cancer Res; 2000 May; 6(5):2028-36. PubMed ID: 10815929
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.